Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:45:21 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Q:CERE - CEREVEL THERAPEUTICS HLDGS INC - http://www.ceres.net
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CERE - Q0.138.84·43.710.242.47+0.401.0680.928,5574,84842.02  42.491  41.9343.5898  19.59Apr 26Apr 1815 min RT 2¢

Recent Trades - Last 10 of 4848
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 06:30U:CERENews ReleaseCerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
2023-12-09 08:42U:CERENews ReleaseSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, NWLI, ROVR, WAVD
2023-12-06 16:30U:CERENews ReleaseAbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
2023-11-29 06:30U:CERENews ReleaseCerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson ¢ € ™s Disease
2023-11-08 06:30U:CERENews ReleaseCerevel Therapeutics to Present at Upcoming Investor Conferences
2023-11-01 06:30U:CERENews ReleaseCerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
2023-10-13 06:30U:CERENews ReleaseCerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023
2023-10-11 22:45U:CERENews ReleaseCerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock
2023-10-11 16:01U:CERENews ReleaseCerevel Therapeutics Announces Proposed Public Offering of Common Stock
2023-08-29 06:30U:CERENews ReleaseCerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-02 06:30U:CERENews ReleaseCerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
2023-07-05 06:30U:CERENews ReleaseCerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023
2023-06-15 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer
2023-05-10 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
2023-05-03 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results